Desogestrel
Sponsors
Chugai Pharmaceutical Co. Ltd., University Of Debrecen, Assistance Publique - Hôpitaux de Paris, Children's Hospital Los Angeles, Mahidol University
Conditions
Congenital Central Hypoventilation SyndromeDysfunctional Uterine BleedingEndometriosisOndine SyndromeUterine LeiomyomaVenous Thromboembolism Risk associated with Hormonal Contraceptives
Phase 2
Assessment of Desogestrel in Ondine Syndrome
CompletedNCT01243697
Start: 2011-04-30End: 2013-09-30Updated: 2013-11-14
Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome
TerminatedNCT01500473
Start: 2012-02-29End: 2016-05-11Updated: 2023-11-18
A PHASE II, RANDOMIZED, DOUBLE BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AMY109 IN WOMEN WITH ENDOMETRIOSIS
Active, not recruitingCTIS2023-507289-14-00
Start: 2024-10-21Target: 80Updated: 2026-01-15
Phase 3
Phase 4
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
TerminatedNCT01738724
Start: 2012-01-31End: 2017-12-31Updated: 2020-08-13
Evaluation of Thrombin Generation and Thrombosis Risk in Women on Hormonal Contraceptives with a Focus on Modifiable Risk Factors
Not yet recruitingCTIS2026-527084-15-00
Target: 350Updated: 2026-10-07